Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

6.40
Delayed Data
As of 4:00pm ET
 +0.24 / +3.90%
Today’s Change
3.70
Today|||52-Week Range
9.22
+11.89%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close6.16
Today’s open6.18
Day’s range6.05 - 6.40
Volume27,144
Average volume (3 months)29,803
Market cap$120.8M
Dividend yield--
Data as of 4:00pm ET, 05/06/2016

Growth & Valuation

Earnings growth (last year)-11.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+33.56%
P/E ratioNM
Price/Sales5.42
Price/Book2.94

Competitors

 Today’s
change
Today’s
% change
TTNPTitan Pharmaceutical...-0.66-11.50%
PRQRProQR Therapeutics N...+0.05+1.06%
AGLEAeglea Bio Therapeut...+0.10+1.10%
ORMPOramed Pharmaceutica...-0.24-2.63%
Data as of 4:00pm ET, 05/06/2016

Financials

Last reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$20.1M
Annual profit (last year)-$12.8M
Net profit margin-63.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs